A stress-activated mid-insula to BNST pathway regulates susceptibility to abstinence-induced negative affect in female mice
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 7, 2025
Stress
is
central
to
many
neuropsychiatric
conditions,
including
alcohol
use
disorder
(AUD).
influences
the
initiation
and
continued
of
alcohol,
progression
AUD,
relapse.
Identifying
neurocircuits
activated
during
stress,
individual
variability
in
these
responses
critical
for
developing
new
treatment
targets
particularly
mitigate
stress-induced
Using
a
longitudinal
approach,
this
study
examined
relationship
between
sub-chronic
stress
exposure
negative
affect
protracted
abstinence
following
chronic
ethanol
exposure.
Sub-chronic
restraint
heightened
affect-like
behavior
abstinence.
Interestingly,
was
driven
by
subset
"stress-susceptible"
female
mice.
We
mid-insula,
hub
brain's
salience
network,
as
driver
effect,
given
its
role
emotional
regulation
links
craving,
consumption,
abstinence-induced
affect.
Mid-insula
GCaMP
fiber
photometry
revealed
that
activity
positively
correlated
with
novelty-suppressed
feeding
test
(NSFT)
two
weeks
into
A
distinct
mice
exhibited
increasing
consummatory
phase,
implicating
mid-insula
neural
basis
Chemogenetic
inhibition
neurons
projecting
dorsal
BNST
disrupted
emergence
susceptibility,
highlighting
circuit
key
determinant
susceptibility
These
outcomes
were
female-specific,
addressing
gap
understanding
AUD
risk
women.
Furthermore,
higher
struggling
than
males.
However,
effect
blocked
chemogenetic
insula-BNST
pathway
stress.
By
linking
pre-alcohol
response
outcomes,
work
positions
potential
biomarker
therapeutic
target.
Language: Английский
Addiction and stress: Exploring the reward pathways in brain affected by different drugs
Samira Rostami Mehr,
No information about this author
Babak Nakhaei,
No information about this author
Hossein Soleimani
No information about this author
et al.
Progress in brain research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Epigenetic Insights into Substance Use Disorder and Associated Psychiatric Conditions
A. Ngo,
No information about this author
Christopher M Ahmad,
No information about this author
Niki Gharavi Alkhansari
No information about this author
et al.
Complex Psychiatry,
Journal Year:
2025,
Volume and Issue:
11(1), P. 12 - 36
Published: March 3, 2025
Background:
Substance
use
disorder
(SUD)
is
closely
associated
with
epigenetic
modifications
that
significantly
impact
mental
health
outcomes.
Alcohol
and
drug
misuse
induce
widespread
changes
in
the
epigenome
transcriptome
of
central
nervous
system,
disrupting
critical
processes
such
as
reward
signaling
emotional
regulation.
These
alterations
regulation
gene
expression
often
persist
even
after
substance
cessation,
potentially
contributing
to
onset
or
worsening
psychiatric
conditions,
including
schizophrenia,
depression,
stress,
anxiety.
Summary:
This
review
delves
into
key
mechanisms
underlying
SUD
its
comorbid
disorders,
a
focus
on
DNA
methylation,
histone
modifications,
noncoding
RNA
Additionally,
it
examines
influence
environmental
biological
factors
evaluates
emerging
epigenetic-based
therapeutic
strategies
aimed
at
treating
related
conditions.
Key
Messages:
Gaining
deeper
understanding
driving
disorders
crucial
for
development
effective
interventions.
highlights
potential
pharmacological
mitigate
societal
personal
burdens
linked
complications.
Language: Английский
Mental health and well-being in business-to-business markets
Industrial Marketing Management,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Language: Английский
Digital Detection of Craving and Stress for Individuals in Recovery from Substance Use Disorder: A Qualitative Study
Jazmin Hampton,
No information about this author
Reynalde Eugene,
No information about this author
Nirzari Kapadia
No information about this author
et al.
Drug and Alcohol Dependence Reports,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100336 - 100336
Published: April 1, 2025
Language: Английский
Salivary cortisol trajectories among inpatients undergoing substance use disorder treatment: A prospective repeated-measures study
Eli Otterholt,
No information about this author
Petter Laake,
No information about this author
Stål Bjørkly
No information about this author
et al.
Psychoneuroendocrinology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 107477 - 107477
Published: April 1, 2025
Language: Английский
Interaction between corticotropin-releasing factor, orexin, and dynorphin in the infralimbic cortex may mediate exacerbated alcohol-seeking behavior
Neurobiology of Stress,
Journal Year:
2024,
Volume and Issue:
33, P. 100695 - 100695
Published: Nov. 1, 2024
A
major
challenge
for
the
treatment
of
alcohol
use
disorder
(AUD)
is
relapse
to
use,
even
after
protracted
periods
self-imposed
abstinence.
Stress
significantly
contributes
chronic
relapsing
nature
AUD,
given
its
long-lasting
ability
elicit
intense
craving
and
precipitate
relapse.
As
individuals
transition
dependence,
compensatory
allostatic
mechanisms
result
in
insults
hypothalamic-pituitary-adrenal
axis
function,
mediated
by
corticotropin-releasing
factor
(CRF),
which
subsequently
hypothesized
alter
brain
reward
pathways,
influence
affect,
craving,
ultimately
perpetuate
problematic
drinking
vulnerability.
Orexin
(OX;
also
called
hypocretin)
plays
a
well-established
role
regulating
diverse
physiological
processes,
including
stress,
has
been
shown
interact
with
CRF.
Interestingly,
most
hypothalamic
cells
that
express
Language: Английский